Q-Med: Record date delayed for 4:1 share split

By E. Janene Geiss

Philadelphia, May 24 - Q-Med AB said Wednesday that it is postponing its planned record date for its 4:1 share split for administrative reasons.

Officials said it would postpone its originally planned May 31 date by a few weeks. More information may be announced next week, according to a company news release.

Shareholders at the May 4 general meeting adopted the split, whereby one share is replaced by four new shares of the same kind.

Shares of the company trade on the Pink Sheets under the symbol QMDAF.

Q-Med is a Stockholm, Sweden, biotechnology and medical device company that develops and sells medical implants, including Restylane for wrinkles and Durolane to treat osteoarthritis of the hip and knee joints.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.